Sangoma Technologies Corporation SANG
3.59
0.04
1.13%
as of 25 Sep
- Market cap
- $118.1M
- P/E
- 0.0×
Follow SANG
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.61 | 0.76 | 0.72 | 0.86 | |
P/FCF ratio |
4.99 | 5.47 | 5.04 | 5.14 | |
P/Operating CF |
21.53 | 16.57 | 33.05 | 28.44 | |
P/B ratio |
0.52 | 0.67 | 0.65 | 0.80 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.62 | 0.79 | 0.77 | 0.94 | |
EV/EBITDA |
4.18 | 5.22 | 5.09 | 6.27 | |
EV/Operating CF |
4.65 | 5.29 | 5.08 | 5.34 | |
EV/FCF |
5.08 | 5.66 | 5.43 | 5.66 | |
Quick Ratio |
0.59 | 0.59 | 0.60 | 0.60 | |
Current Ratio |
0.90 | 0.87 | 0.87 | 0.86 | |
Net Debt/EBITDA |
0.34 | 0.82 | 1.71 | 2.00 | |
Debt/Assets |
5.52% | 7.09% | 8.47% | 9.83% | |
Debt/Equity |
0.07 | 0.09 | 0.11 | 0.13 | |
Asset Turnover |
0.63 | 0.63 | 0.63 | 0.63 | |
Operating CF/Net income |
(2.56) | (5.08) | (2.11) | 34.10 | |
Capex/Depreciation |
(0.10) | (0.05) | (0.03) | (0.09) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
21.12% | 20.24% | 22.26% | 16.88% | |
Selling, General and Administrative Expense of Revenue |
38.69% | 41.90% | 37.33% | 35.16% | |
Intangible Assets out of Total Assets |
0.80 | 0.80 | 0.80 | 0.80 | |
Share Based Compensation of Revenue |
0.85% | 1.61% | 1.04% | 1.05% | |
Graham Net Nets |
(0.22) | (0.21) | (0.26) | (0.25) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(4.98%) | (3.22%) | (3.33%) | (2.54%) | |
Free Cash Flow Yield |
20.05% | 18.29% | 19.85% | 19.44% | |
Revenue per Share |
1.54 | 1.55 | 1.53 | 1.77 | |
Operating CF per Share |
0.18 | 0.31 | 0.15 | 0.21 | |
Capex per Share |
(0.03) | (0.01) | (0.01) | (0.02) | |
Free Cash Flow per Share |
0.15 | 0.29 | 0.14 | 0.19 | |
Cash per Share |
0.46 | 0.52 | 0.48 | 0.41 | |
Shareholders Equity per Share |
7.49 | 7.55 | 7.56 | 7.59 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.49 | 7.55 | 7.56 | 7.59 | |
Free Cash Flow |
5.08 | 9.71 | 4.70 | 6.30 | |
Working Capital |
(4.61) | (5.89) | (6.34) | (6.85) | |
Capital Expenditures |
(0.90) | (0.42) | (0.24) | (0.82) | |
Net Current Asset Value |
(28.33) | (35.47) | (42.69) | (49.73) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.01 | 0.00 | 0.01 | |
Net Profit Margin |
(4.58%) | (3.88%) | (4.60%) | 0.35% | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
10.96 | 12.51 | 16.00 | 17.94 | |
Average Payables |
18.15 | 17.28 | 18.03 | 18.50 | |
Average Inventory |
8.53 | 10.19 | 10.67 | 11.50 | |
Average Assets |
339.43 | 349.55 | 362.28 | 373.60 | |
Average Common Equity |
251.83 | 253.67 | 254.83 | 256.96 |
Columns are period end dates